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“Do I Have to Be Tested?”:
Understanding Reluctance to Be
Screened for COVID-19
A 35-year-old recent immi-
grant from El Salvador calls an
immigrant hotline in May 2020,
reporting five days of cough,
muscle aches, fever, and chills.
Coronavirus disease 2019
(COVID-19) testing is ordered.
When offered the testing ap-
pointment, he declines. The
clinician wonders what sort of
person would decline COVID-19
testing.
Widespread severe acute re-
spiratory syndrome coronavirus 2
(SARS-CoV-2) testing by public
health systems is widely ac-
knowledged as necessary. Many
communities distrust these sys-
tems, however, given their his-
tories of racist treatment1 and
their current roles in perpetuating
inequities in health outcomes.
Those outcomes are driven by
both racial and class inequities
beyond public health systems and
exacerbated by economic barriers
to and discrimination within
health care. Racialized ineq-
uities are further exacerbated by
America’s immigration policies
and practices. Together, these
dynamics explain the dispropor-
tionately higher COVID-19
mortality rates in Black and
Latinx communities.2
To understand and address
why members of minority
communities might decline
testing, then, we must situate the
pandemic and the public health
responses to it within both the
ethnoracial dynamics of everyday
life in America and the racialized
state (in)actions in the face of
emergencies. The current pan-
demic is the latest emergency
inordinately affecting American
communities of color. These
emergencies are often described
as natural disasters, but their in-
equitable effects reflect the social
organization of “normal” life.
Neighborhoods damaged by
Hurricane Katrina, for instance,
featured significantly more resi-
dents of color and lesswealth than
did undamaged neighborhoods.
This pattern reflected the status
quo ante, in which conditions in
the former neighborhoods ren-
dered them most susceptible not
just to high winds and flooding
but also to all the hurricane’s
sequelae.
This legacy has consequences.
Distrust of the state because of
racist and classist government (in)
actions has been a key reason that
some communities have not
heeded mandatory evacuation
orders3—a useful parallel to
mandatory pandemic measures
such as safer-at-home poli-
cies; this must be considered in
assessing contradictory data about
support for and adherence to
COVID-19 response measures,
including testing.4
Given this combination of
experiences within and among
American communities of color,
an effective and ethically sound
mandatory testing program re-
quires addressing the specific
barriers that members of these




First, a fundamental question:
what does mandatory mean?
COVID-19 testing is not re-
quired by law anywhere in
the United States, but most
COVID-19 testing reported as
voluntary has been required by
schools, employers, and institu-
tions for their constituents to
return to in-person activities.
The return of students and
workers to in-person operations
at many universities, for example,
is conditional on compliance
with testing requirements (e.g.,
students twice aweek; employees
once a week). This example
highlights challenges of privilege,
consent, and coercion for various
groups, even absent legal force.
Financial Barriers
Throughout this pandemic,
many in the United States have
had to choose between exposing
themselves and their families to
infection and making a living.
Workers at meat-processing
plants are a prime example: nearly
200 plants nationwide have re-
ported cases.5 Workers at many
plants are poorly paid and do not
receive sick leave. Furthermore,
recent government action pro-
tects these plants from liability for
employee illness. Employees
who receive positive test results
are thus forced to choose be-
tween the “ethically responsible”
choice of staying home and the
need to earn money to ensure
food and shelter.
Mandatory testing, and thus
mandatory quarantine for those
who test positive, is destined to
fail if testing positive augurs fi-
nancial ruin for large segments of
the population. Similar dilemmas
confront workers at Amazon,
Walmart, and other businesses in
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constitute a significant percent-
age of frontline and essential
workers. These communities are
more vulnerable to SARS-CoV-
2, largely because their jobs place
them at higher risk for infection
(such as restaurant andwarehouse
work). They are unable to access
the social services available to US
citizens, which were inadequate
even before the pandemic, and
are actively discouraged from
seeking health care because of the
Public Charge Rule, which
counts an individual’s use of
public resources against him or
her in immigration hearings.
Many undocumented immi-
grants and foreign-born indi-
viduals fear that COVID-19
testing might be used as a pretext
to deport them from the United
States.
Fear of Repercussions
COVID-19 testing in proce-
dural or surgical settings is now a
near-universal practice; the re-
percussions of such testing are
significant. Many women and
their partners fear separation from
their infant if their test result is
positive, for example, and no
standardized guidelines exist on
disposition of the neonate from a
mother with COVID-19. This is
particularly a concern for un-
documented immigrants because
many fear deportation as a con-
sequence of separation. In addi-
tion, no standard protocol has
been established for postpartum
follow-up, and women with
COVID-19 may fear receiving
substandard or stigmatized care.
Stigma and Stereotype
Threat
Testing for HIV and other
sexually transmitted infections
continues to be stigmatized.
Similarly, already marginalized
communities are further disad-
vantaged because of their
perceived association with SARS-
CoV-2. Discrimination and
physical violence against Asians,
Latinx, Hasidic Jews, African
Americans, and others have been
amply documented; at both the
communal and the individual
level, these threats disincentivize
participation in testing. Stereo-
type threat may further dis-
incentivize members of these
communities from pursuing test-
ing out of concern that testing
positive would confirm prejudices.
Research Aversion
The history of medical re-
search in the United States is
replete with racist violence and
exploitation. As a result, distrust
of medical research is widespread
among Black and other minority
communities.6 COVID-19 test-
ing that occurs in the context of
research, including clinical trials,
thus will face suspicion from
members of communities who
have been harmed under the




The pandemic has intensified
preexisting debates about scien-
tific expertise. Public awareness
of replication crises, alongside the
use of empirically unreliable
claims packaged in scientific
terminology, methodology, and
publication (e.g., the vaccine-
autism link), have compounded
an underlying mistrust of clini-
cians, as well as the too-often
malignant or negligent relations
between health care institutions
and communities of color.
Misinformation and disinfor-
mation (e.g., the claim that
Black people are immune to
COVID-19 and, conversely, that
the virus was manufactured to
harm communities of color) thus
worsen extant estrangement be-
tween communities of color and
public health institutions and
their sets of knowledge sources
and practitioners. Furthermore,
the sources of misinformation
and disinformation are often
more trusted than the public
health institutions. Those insti-
tutions’ attempts to condemn or






and the common good is a fun-
damental ethical challenge for
public health. Testing policies
that encroach on the autonomy
of individual members of vul-
nerable communities will likely
infringe on the rights of the
vulnerable while yielding too
little test coverage to benefit the
population. Testing must be
made an attractive option for all
through earning community
trust. One potential approach,
testing and contract tracing as a
case-finding method, cannot be
implemented in a way that earns
such trust if positive results con-
tinue to require reporting with
full identifiers (e.g., in HIV case
finding). By contrast, testing as a
surveillance method (anony-
mous-unlinked) would be less
infringing.
Unidirectional messaging
campaigns will not solve “poor
compliance” with COVID-19
testing or prevention; in fact, they
can further estrange communities
that must be enlisted in these
efforts.7 It is unwise to assume
that vulnerable communities do
not have facts about COVID-19
(or other health issues) and in-
sufficient to ensure simply that
they do have those facts, espe-
cially when they are excluded
from the processes through
which these facts are discovered
and disseminated. If such com-
munities are to be fully and ef-
fectively included in public
health efforts, the social and po-
litical structures that harm them,
and lead to recurring harmful
consequences, must be disman-
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